Darolutamide combo is an ARASENSible option for mHSPC
Crossref DOI link: https://doi.org/10.1038/s41585-022-00579-0
Published Online: 2022-03-02
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fenner, Annette
Text and Data Mining valid from 2022-03-02
Version of Record valid from 2022-03-02
Article History
First Online: 2 March 2022